Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1361962 | Bioorganic & Medicinal Chemistry Letters | 2011 | 4 Pages |
Three series of butenolide-containing dithiocarbamates were designed and synthesized. Their anti-tumor activity in vitro was evaluated. Among them compound I-14 exhibited broad spectrum anti-cancer activity against five human cancer cell lines with IC50 <30 μM. Structure–activity relationship analysis showed that the introduction of dithiocarbamate side chains on the C-3 position of butenolide was crucial for anti-tumor activity.
Graphical abstractThree series of butenolide-containing dithiocarbamates were designed and synthesized. Their anti-tumor activity in vitro was evaluated. Among them compound I-14 exhibited excellent anti-cancer activity against five human cancer cell lines with IC50 <10 μg/mL. Structure–activity relationship analysis showed that the introduction of dithiocarbamate side chains on the C-3 position of butenolide was crucial for anti-tumor activity.Figure optionsDownload full-size imageDownload as PowerPoint slide